Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
6 studies found for:    HLA-C
Show Display Options
Rank Status Study
1 Not yet recruiting Maternal and Fetal Compatibility in ART-oocyte Donor Influences Live Birth Rate
Condition: Infertility
Intervention: Genetic: KIR HLAC determinations
2 Unknown  Maternal KIR and Fetal HLA-C Genes in Recurrent Miscarriages
Condition: Recurrent Miscarriages
Intervention:
3 Completed
Has Results
Donor Stem Cell Transplant in Treating Patients With Myeloid Cancer or Other Disease
Conditions: Leukemia;   Myelodysplastic Syndromes
Interventions: Biological: anti-thymocyte globulin;   Drug: fludarabine phosphate;   Drug: thiotepa;   Procedure: peripheral blood stem cell transplantation;   Radiation: total-body irradiation
4 Completed NGS for HLA Typing of Donors and récipients oh Hematopoietic Stem Cells
Condition: Next Generation Sequencing for HLA Typing
Intervention:
5 Unknown  Adoptive Immunotherapy of High Risk Acute Myeloblastic Leukemia Patients Using Haploidentical Kir Ligand-mismatched Natural Killer Cells
Condition: Myeloblastic Leukemia
Intervention: Biological: NK cells
6 Unknown  bLAC - Treatment of Cutaneous Warts in Immune Suppressed, Kidney Transplanted Patients
Condition: Cutaneous Warts
Interventions: Drug: bLAC;   Drug: Placebo

Indicates status has not been verified in more than two years